Cut-and-count biodistribution studies showed tumor uptake in PSN1 xenografts amounted to 0.9 ± 0.06 %IA/g at 1 h after intravenous administration, and normal-tissue uptake was in line with dynamic SPECT imaging (Fig. 4C). Here, NT5C3A is linked to neoplasm.